ProCE Banner Activity

Looking Toward the Future: BTKi-Based Combination Therapy

Slideset Download
In this downloadable slideset, Andrew D. Zelenetz, MD, PhD, examines the potential of combining BTK inhibitors with other therapies in patients with B-cell malignancies.

Released: June 05, 2019

Expiration: June 03, 2020

No longer available for credit.

Share

Faculty

Andrew D. Zelenetz

Andrew D. Zelenetz, MD, PhD

Associate Professor, Department of Medicine
Cornell University Medical College
Chief, Lymphoma Service
Memorial Sloan-Kettering Cancer Center
New York, New York

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

AstraZeneca

Program Director Disclosure

Program Director

Andrew D. Zelenetz, MD, PhD

Associate Professor, Department of Medicine
Cornell University Medical College
Chief, Lymphoma Service
Memorial Sloan-Kettering Cancer Center
New York, New York